• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?

作者信息

Kalil Andre C, Holubar Marisa, Deresinski Stan, Chambers Henry F

机构信息

Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA

Division of Infectious Diseases, Stanford University, Stanford, California, USA.

出版信息

Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00900-19. Print 2019 Nov.

DOI:10.1128/AAC.00900-19
PMID:31640977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6811451/
Abstract
摘要

相似文献

1
Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?与金黄色葡萄球菌菌血症的标准治疗单药疗法相比，达托霉素加头孢洛林是否具有更好的临床疗效？
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00900-19. Print 2019 Nov.
2
Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?".对卡利尔等人《达托霉素联合头孢洛林治疗金黄色葡萄球菌菌血症是否比标准治疗单药疗法具有更好的临床疗效？》一文的回复
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.01347-19. Print 2019 Nov.
3
Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?达托霉素联合头孢托罗琳是治疗耐甲氧西林金黄色葡萄球菌菌血症的可行方法吗？
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.01725-19. Print 2019 Nov.
4
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.达托霉素联合头孢洛林与标准护理单药治疗耐甲氧西林金黄色葡萄球菌菌血症的临床数据。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02483-18. Print 2019 May.
5
Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant Bacteremia-A Meta-Analysis.头孢洛林联合万古霉素或达托霉素与万古霉素或达托霉素单药治疗耐甲氧西林菌血症成人患者的疗效比较——一项荟萃分析
Antibiotics (Basel). 2022 Aug 15;11(8):1104. doi: 10.3390/antibiotics11081104.
6
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.耐甲氧西林金黄色葡萄球菌引起的菌血症：新的治疗方法
Infect Dis Clin North Am. 2016 Jun;30(2):491-507. doi: 10.1016/j.idc.2016.02.009.
7
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.头孢洛林酯单药治疗耐甲氧西林金黄色葡萄球菌菌血症：一项比较临床结局研究。
Int J Infect Dis. 2017 Apr;57:27-31. doi: 10.1016/j.ijid.2017.01.019. Epub 2017 Jan 25.
8
Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia.达托霉素及达托霉素-头孢洛林联合用药作为持续性耐甲氧西林金黄色葡萄球菌菌血症的挽救治疗方案
Infect Dis (Lond). 2018 Aug;50(8):643-647. doi: 10.1080/23744235.2018.1448110. Epub 2018 Mar 6.
9
A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).头孢洛林与达托霉素联用具有协同杀菌作用，可体外抑制达托霉素中介耐甲氧西林金黄色葡萄球菌（MRSA）。
Infect Dis (Lond). 2017 May;49(5):410-416. doi: 10.1080/23744235.2016.1277587. Epub 2017 Jan 24.
10
Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.万古霉素联合头孢洛林治疗持续性耐甲氧西林金黄色葡萄球菌菌血症。
Pharmacotherapy. 2023 Jan;43(1):15-23. doi: 10.1002/phar.2741. Epub 2022 Nov 21.

引用本文的文献

1
Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment.耐甲氧西林和敏感金黄色葡萄球菌：耐受性、免疫逃避与治疗
Nat Rev Microbiol. 2025 Aug 20. doi: 10.1038/s41579-025-01226-2.
2
Early initiation of ceftaroline-based combination therapy for methicillin-resistant Staphylococcus aureus bacteremia.基于头孢洛林的联合疗法用于耐甲氧西林金黄色葡萄球菌菌血症的早期启动。
Ann Clin Microbiol Antimicrob. 2025 Jan 13;24(1):3. doi: 10.1186/s12941-025-00773-z.
3
Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis.复杂性革兰氏阳性菌血症和感染性心内膜炎的治疗
Drugs. 2025 Feb;85(2):193-214. doi: 10.1007/s40265-024-02135-z. Epub 2024 Dec 25.
4
Comparative effectiveness of daptomycin versus vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: A systematic literature review and meta-analysis.比较耐甲氧西林金黄色葡萄球菌（MRSA）血流感染患者使用达托霉素与万古霉素的疗效：系统文献回顾和荟萃分析。
PLoS One. 2024 Feb 21;19(2):e0293423. doi: 10.1371/journal.pone.0293423. eCollection 2024.
5
Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.金黄色葡萄球菌菌血症的当代管理-临床实践中的争议。
Clin Infect Dis. 2023 Nov 30;77(11):e57-e68. doi: 10.1093/cid/ciad500.
6
Emerging Treatment Options for Acute Bacterial Skin and Skin Structure Infections and Bloodstream Infections Caused by : A Comprehensive Review of the Evidence.新兴的针对由[病原体]引起的急性细菌性皮肤及皮肤结构感染和血流感染的治疗选择：证据的全面综述
Infect Drug Resist. 2022 Apr 22;15:2137-2157. doi: 10.2147/IDR.S318322. eCollection 2022.
7
Select controversies in the management of methicillin-resistant bacteremia: answers and remaining questions from recent evidence.耐甲氧西林菌血症管理中的争议：近期证据给出的答案及遗留问题
Fac Rev. 2021 Aug 31;10:66. doi: 10.12703/r/10-66. eCollection 2021.
8
Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients?耐甲氧西林金黄色葡萄球菌（MRSA）菌血症的联合治疗现状：是否有效、哪种联合治疗、针对哪些患者？
Clin Infect Dis. 2021 Dec 16;73(12):2353-2360. doi: 10.1093/cid/ciab452.
9
The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.β-内酰胺类药物在耐甲氧西林金黄色葡萄球菌血流感染治疗中的新作用
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00468-20.

本文引用的文献

1
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.达托霉素联合头孢洛林与标准护理单药治疗耐甲氧西林金黄色葡萄球菌菌血症的临床数据。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02483-18. Print 2019 May.
2
The Fragility Index in Randomized Clinical Trials as a Means of Optimizing Patient Care.随机临床试验中的脆弱指数作为优化患者护理的手段。
JAMA Surg. 2019 Jan 1;154(1):74-79. doi: 10.1001/jamasurg.2018.4318.